058sek
19,4 %
Date:2026-04-17Time:18:00:00Latest report:Q3-2026List:First NorthTicker:QCORE
Market Cap:25 msekEnterprise Value:15 msekNet Sales:8,25 msekEarnings:-35,1 msekEmployees:0ISIN:SE0016829824

Ratios

10-year key figure history for Qlucore turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Qlucore with index and moving average MA50 and MA200.

Stockprice:0,58
MA50:0,43
MA200:0,54
Price/MA200:6,8 %
RSI (14):77,0
Price/MA50:35,5 %

Description

Qlucore develops AI-based software for use in the healthcare sector. The company's precision medicine solutions transform genetic data into decision-making data to create the right treatment for patients. The company's first diagnostic test – for blood cancer in children – has been approved and CE-marked. The company also has tests for lung cancer under development, and is developing the Qlucore Omics Explorer analysis software.

IT Services